NCT02930798 is a NA clinical trial of BAY987516 in Sunscreening Agents, sponsored by Bayer.

Who is sponsoring NCT02930798?

NCT02930798 is sponsored by Bayer.

What drugs are being tested in NCT02930798?

Interventions in NCT02930798: BAY987516.

What condition does NCT02930798 study?

NCT02930798 studies Sunscreening Agents.

Is NCT02930798 still recruiting?

NCT02930798 is currently completed. Last updated 13 December 2018.

Last reviewed 2018-12-13 · How we verify

NCT02930798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sun Protection Factor Assay (SPF Assay 203/2016)

Completed NA Last updated 13 December 2018

What this trial tests

NA trial testing BAY987516 in Sunscreening Agents in 3 participants. Completed in 19 October 2016.

Timeline

18 October 2016

Primary endpoint
19 October 2016

19 October 2016

Quick facts

Lead sponsor	Bayer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	3
Start date	18 October 2016
Primary completion	19 October 2016
Estimated completion	19 October 2016
Sites	1 location across United States

Drugs / interventions tested

BAY987516 — full drug profile →

Conditions studied

Sunscreening Agents — all drugs for Sunscreening Agents →

Sponsor

Bayer — full company profile →

Who can join

Adults 18 to 70, any sex, with Sunscreening Agents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the Sun Protection Factor efficacy on human skin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of BAY987516

Trials testing the same drug.

NCT02995122 — Sun Protection Factor Assay (339/2016) · NA · completed
NCT02930746 — Sun Protection Factor Assay (SPF Assay 199/2016) · NA · completed
NCT02930759 — Sun Protection Factor Assay (SPF Assay 200/2016) · NA · completed
NCT02930772 — Sun Protection Factor Assay (SPF Assay 201/2016) · NA · completed
NCT02885805 — Sun Protection Factor (SPF) Efficacy Assay · NA · completed

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02930798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 13 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02930798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing